Prognostic model integrating histology, systemic inflammation, and recurrence status predicts immunotherapy response in advanced non-small-cell lung cancer patients.
Saved in:
| Title: | Prognostic model integrating histology, systemic inflammation, and recurrence status predicts immunotherapy response in advanced non-small-cell lung cancer patients. |
|---|---|
| Authors: | Moiseenko, F. V.1,2,3 (AUTHOR), Krasavina, M. A.1 (AUTHOR), Agranov, I. R.1 (AUTHOR), Artemieva, E. V.1 (AUTHOR), Oganesian, A. P.1,2 (AUTHOR), Gabina, A. S.1,2 (AUTHOR), Makarkina, M. L.1 (AUTHOR), Elsakova, E. O.1 (AUTHOR), Henshtein, V. A.1 (AUTHOR), Volkov, N. M.1 (AUTHOR), Egorenkov, V. V.1 (AUTHOR), Moiseenko, V. M.1 (AUTHOR), Fedyanin, M. Yu.4,5,6 (AUTHOR), Kopeina, G. S.7,8 (AUTHOR), Zhivotovsky, B.7,8,9 (AUTHOR) boris.zhivotovsky@ki.se, Zamaraev, A. V.7,8 (AUTHOR) a-zamaraev@yandex.ru |
| Source: | Biology Direct. 7/3/2025, Vol. 20 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17456150 |
|---|---|
| DOI: | 10.1186/s13062-025-00674-3 |
